Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNew site revision label 'Revision: v3.6.6' has been added, replacing the previous 'Revision: v3.6.5'. This marks a software update on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedA new revision entry v3.6.5 has been added to the study record. The Plain Language Summary and the prior revision entry v3.6.4 have been removed, affecting lay reader readability and the revision history.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision label 'Revision: v3.6.4' was added, replacing the previous 'Revision: v3.6.3', indicating a small backend update to the page's versioning.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. It reflects a small backend update with no changes to the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0, signaling a minor page revision. This update appears to be a label-only change and does not modify the study content or results.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page now indicates recruitment is closed for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), along with a formatting adjustment from 'Intervention / Treatment' to 'Intervention/Treatment' and a new revision version (v3.6.0).SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.